37
Participants
Start Date
September 1, 2020
Primary Completion Date
February 22, 2023
Study Completion Date
March 27, 2023
Guselkumab
100 mg guselkumab administered subcutaneously
Placebos
Sodiumchloride 0,9% solution for injection
Centre for Human Drug Research, Leiden
Collaborators (1)
Janssen Pharmaceuticals
INDUSTRY
Centre for Human Drug Research, Netherlands
OTHER